Arcellx (ACLX) Interest Expenses (2021 - 2025)
Arcellx's (ACLX) quarterly Interest Expenses came in at -$12000.0 in Q4 2025, down 271.43% year-on-year from $7000.0 in Q4 2024, and down 112.24% quarter-over-quarter from $98000.0 in Q2 2025.
Arcellx (ACLX) Interest Expenses (2021 - 2025) Analysis & Trends
Arcellx's Interest Expenses history runs 5 years deep, the most recent figure standing at -$12000.0 for Q4 2025.
- On a quarterly basis, Interest Expenses fell 271.43% year-over-year to -$12000.0 in Q4 2025; TTM through Dec 2025 was $109000.0, a 89.42% decrease from a year earlier, with the FY2025 full-year figure at $304.6 million, down 26.71% from the prior year.
- Interest Expenses fell to -$12000.0 in Q4 2025 per ACLX's latest filing, from $98000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $192.0 million in Q3 2023 and bottomed at -$12000.0 in Q4 2025.
- The 5-year median for Interest Expenses is $1.2 million (2023), against an average of $47.0 million.
- Across the five-year window, Interest Expenses surged 281.43% in 2023 and plunged 271.43% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $38.7 million in 2021, then sank by 98.63% to $529000.0 in 2022, then soared by 228.54% to $1.7 million in 2023, then slumped by 99.6% to $7000.0 in 2024, then plunged by 271.43% to -$12000.0 in 2025.
- Per Business Quant, the three latest ACLX Interest Expenses figures stand at -$12000.0 (Q4 2025), $98000.0 (Q2 2025), and $87000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 321,000.00 |
| Jun 30, 2024 | 321,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Dec 31, 2023 | 1.74 Mn |
| Dec 31, 2023 | 1.74 Mn |
| Sep 30, 2023 | 191.98 Mn |
| Sep 30, 2023 | 191.98 Mn |
| Jun 30, 2023 | 167.17 Mn |
| Jun 30, 2023 | 167.17 Mn |